Eventide Funds are a product of   Eventide Asset Management   Leaving Eventide Product Page

Ticker

ETIEX

$14.06 ▼ -0.42% 12/17/2024

Nav

$14.06 ▼ -0.42% 12/17/2024

About the Fund

  • Non-diversified approach
  • Investments concentrated in information technology and communication sectors
  • May invest in illiquid securities

Annualized Returns

1-Year6.84%
5-Year—
10-Year—
Since Inception5.12%

Morningstar

★

US Fund Technology

Fact Sheet Prospectus

The Eventide Exponential Technologies Fund Launched on 06/30/2020

Morningstar overall star rating is as of 09/30/2024 for the Fund's Class I shares compared to 235 funds in the US Fund Technology category. The overall ranking is derived from a weighted average of performance associated with its 3-year, 5-year and 10-year (where applicable) Morningstar Rating metrics. The Morningstar globe ranking is as of 08/31/2024 compared to the sustainability ratings of 1289 funds in its category. Performance is historical and does not guarantee future results. Investment return and principal value will fluctuate with changing market conditions so that when redeemed, shares may be worth more or less than their original cost. Current performance may be lower or higher than the data quoted. Fund expenses: Class I, Gross Expenses 1.51%, Net Expenses 1.44%. The adviser has contractually agreed to waive fees and/or reimburse expenses of the Fund through 10/31/2024. The agreement may be terminated by the Fund’s Board of Trustees only on 60 days’ written notice.

  • Overview

    Overview

    Fund Objective

    Seeks to provide long-term capital appreciation.

    About the Fund

    A concentrated mutual fund representing our thesis regarding long-term capital appreciation in the information technology, communications, internet and direct marketing retail, and healthcare technology and devices industries. (≥80%). The fund has a non-diversified approach in which ≥5% holdings cumulatively can be ≥25% of the fund. May invest in illiquid securities (≤15%).

    Fund Distinctives

    Focused on Small and Mid-sized Companies
    Median market capitalization of $12.3 billion as of 09/30/2024.

    Highly Concentrated and Non-diversified Investment Approach
    Investing in 25-45 companies within select industries seeking a high active share vs benchmark and other technology mutual funds.

    Compelling Value for Society and Other Stakeholders
    Targeting large scale unmet technological needs to address compelling requirements in society.

    There is no guarantee that the Adviser’s approach will produce the desired results. All investments involve risk, including the possible loss of principal. Portfolio Composition is subject to change at any time, and should not be considered investment advice.

  • Performance and Risk

    Trailing Returns (%) As of the quarter ending 09/30/2024

    Eventide Exponential Technologies Fund
    As of 12/17/2024.

    YTD    		3-month1-year3-year5-year10-yearSince InceptionInception Date
    Class I7.41%0.996.84-13.02--5.1206/30/2020
    Class A without load7.08%1.006.62-13.20--4.9006/30/2020
    Class A with 5.75% load0.94%-4.810.50-14.89--3.4506/30/2020
    Class C6.24%0.785.79-13.87--4.1206/30/2020
    Class N7.16%0.926.62-13.20--4.9006/30/2020
    Benchmarks        
    Bloomberg US 2500 Technology Total Return Index23.46%6.2424.36-0.22--9.6906/30/2020
    S&P North American Technology Sector Index41.46%1.8650.5213.42--19.4306/30/2020


    Performance is historical and does not guarantee future results. Investment return and principal value will fluctuate with changing market conditions so that when redeemed, shares may be worth more or less than their original cost. Current performance may be lower or higher than the data quoted. Investors cannot directly invest in an index, and unmanaged index returns do not reflect any fees, expenses, or sales charges. The volatility of an index may be materially different than that of the Fund, and investors should not expect the Fund to achieve the same results as a listed index. This material must be read along with the Fund's prospectus, which may be obtained at eventidefunds.com/prospectus. Performance data current to the most recent month-end may be obtained by calling 1-877-771-EVEN (3836).

    Market Risk AS OF 09/30/2024

    Standard DeviationBetaAlpha(%)R-Squared(%)
    3-yrInception3-yrInception3-yrInception3-yrInception
    Eventide Exponential Technologies I24.5626.160.981.03-13.19-3.6281.5976.89
    Bloomberg US 2500 Technology Total Return Index22.5822.331.001.00--100.00100.00
  • Portfolio
  • Investment Team
    image of Finny Kuruvilla

    Finny Kuruvilla, MD, PhD  serves as Co-Chief Investment Officer and Senior Portfolio Manager for Eventide. He serves as the Lead Portfolio Manager for the Eventide Gilead Fund, the Eventide Healthcare & Life Sciences Fund, and the Eventide Exponential Technologies Fund. He also is a Managing Director for Eventide Ventures, as well as a Founding Member of Eventide. Dr. Kuruvilla has a background in healthcare, statistics, and investing. Concurrent with his early years at Eventide, he was a Principal at Clarus Ventures, a healthcare and life sciences venture capital firm subsequently acquired by Blackstone. Earlier in his career, Dr. Kuruvilla was a postdoctoral research fellow at the Broad Institute of Harvard and MIT, where he led the development of a new microarray between the Broad Institute and a publicly-traded company Affymetrix. Prior to his investing career, Dr. Kuruvilla was resident, chief resident, and fellow at the Brigham and Women’s Hospital and Boston Children’s Hospital, where he cared for adult and pediatric patients suffering from a variety of hematologic, oncologic, and autoimmune disorders. Subsequently, he was a research fellow at MIT where he designed and implemented statistical algorithms involving logistic regression and pseudo-Bayesian expectation maximization. Dr. Kuruvilla holds an MD from Harvard Medical School, a PhD in Chemistry and Chemical Biology from Harvard University, an SM in Electrical Engineering and Computer Science from MIT, and a BS in Chemistry from Caltech.

  • Literature

Mutual funds involve risk including the possible loss of principal. Past performance does not guarantee future results. The Fund typically invests at least 80% of its net assets in companies that the Adviser believes are participating in and benefiting from technologies, innovations, technology themes, or technology trends which can include information technology, e-commerce discretionary, internet media and services, healthcare technology, healthcare devices, or transaction & payment processing services industries. The term “exponential” means the potential for accelerated advancements in underlying technologies that can positively impact capabilities and development cycles of a company's products and services. Not every company in the Fund's portfolio will experience exponential growth, and the Fund is not expected to deliver exponential returns. The Fund's ethical values screening criteria could cause it to under-perform similar funds that do not have such screening criteria. The Fund can invest in smaller-sized companies which may experience higher failure rates than larger companies and normally have a lower trading volume than larger companies. The Fund may experience higher volatility than the general market due to being concentrated in the technology industries. Companies in the technology industries have different risks including but not limited to products becoming obsolete, and entrance of competing products. Communications companies may underperform due to legislative or increased competition. Internet and Direct Marketing Retail companies may underperform due to legislative or increased government supervision. Healthcare Technology and Devices Companies may be heavily dependent on clinical trials with uncertain outcomes and decisions made by the governments and regulatory authorities. Further, these companies are dependent on patent protection. The Fund has non-diversification risk as a high percentage of Fund assets may be invested in a limited number of companies. The Fund can have risk related to option investing. There are special risks associated with investments in foreign companies including exposure to currency fluctuations, less efficient trading markets, political instability and differing auditing and legal standards. The Fund can invest in private companies. Private investments include various risks including but not limited to lack of liquidity, capital commitment risk, and valuation risk. Private companies may not be financially profitable and have uncertain futures, subjecting them to additional risks. The Fund has no history of operations prior to its inception date.

This information is for use with concurrent or prior delivery of a fund prospectus, which can be obtained at https://www.eventidefunds.com/prospectus or by calling 1-877-771-EVEN (3836). Investors should consider a fund's investment objectives, risks, charges and expenses carefully before investing or sending money. Eventide Mutual Funds are distributed by Northern Lights Distributors, LLC, Member FINRA/SIPC, which is not affiliated with Eventide Asset Management, LLC.

Eventide 1130-1521 - 12/18/2024 10:07am